Literature DB >> 24865533

Islet cell response to high fat programming in neonate, weanling and adolescent Wistar rats.

Marlon E Cerf1, Johan Louw.   

Abstract

CONTEXT: High fat programming, by exposure to a high saturated fat diet during fetal and/or lactational life induces metabolic derangements and alters islet cell architecture in neonate and weanling rats.
OBJECTIVE: The present study assessed metabolic changes and islet cell dynamics in response to high fat maintenance during specific developmental periods in adolescent rats, with some parameters also studied in neonate and weanling rats.
METHODS: The experimental groups comprised neonates, weanlings and adolescents maintained on a high fat diet during specific periods of fetal, lactational and/or postnatal life. Control neonates, weanlings and adolescents were maintained on a standard laboratory (control or low fat) diet. Fetal high fat programmed (i.e., maintained on a high fat diet exclusively during fetal life) neonates were insulin resistant.
RESULTS: Weanlings maintained on a high fat diet throughout fetal and lactational life had increased pancreas weights. Fetal high fat programmed adolescents presented a normal phenotype mimicking the control adolescents. Adolescents maintained on a postnatal high fat diet had increased body weights, hyperglycemia, hyperinsulinemia, hyperleptinemia and insulin resistance displaying beta cell hypertrophy and increased islet cell proliferation. Adolescents maintained on a fetal and postnatal high fat diet had increased body weights, hyperleptinemia, hyperinsulinemia and insulin resistance.
CONCLUSIONS: High fat programming induces various diabetogenic phenotypes which present at different life stages. The postnatal period from birth to adolescence represents an extension for high fat programming of metabolic disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24865533     DOI: 10.6092/1590-8577/1534

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  7 in total

1.  Developmental programming of the pancreatic islet by in utero overnutrition.

Authors:  Joseph M Elsakr; Maureen Gannon
Journal:  Trends Dev Biol       Date:  2017

2.  Maternal Western-style diet affects offspring islet composition and function in a non-human primate model of maternal over-nutrition.

Authors:  Joseph M Elsakr; Jennifer C Dunn; Katherine Tennant; Sifang Kathy Zhao; Karly Kroeten; Raymond C Pasek; Diana L Takahashi; Tyler A Dean; Digna R Velez Edwards; Carrie E McCurdy; Kjersti M Aagaard; Alvin C Powers; Jacob E Friedman; Paul Kievit; Maureen Gannon
Journal:  Mol Metab       Date:  2019-04-12       Impact factor: 7.422

3.  Excessive folic acid supplementation in pregnant mice impairs insulin secretion and induces the expression of genes associated with fatty liver in their offspring.

Authors:  Yuri Kintaka; Nobuhiro Wada; Seiji Shioda; Sadako Nakamura; Yuko Yamazaki; Kazuki Mochizuki
Journal:  Heliyon       Date:  2020-04-18

4.  Exposure to maternal obesity programs sex differences in pancreatic islets of the offspring in mice.

Authors:  Lisa M Nicholas; Mototsugu Nagao; Laura C Kusinski; Denise S Fernandez-Twinn; Lena Eliasson; Susan E Ozanne
Journal:  Diabetologia       Date:  2019-11-26       Impact factor: 10.122

Review 5.  Maternal obesity and the impact of associated early-life inflammation on long-term health of offspring.

Authors:  Merve Denizli; Maegan L Capitano; Kok Lim Kua
Journal:  Front Cell Infect Microbiol       Date:  2022-09-16       Impact factor: 6.073

Review 6.  Cardiac Glucolipotoxicity and Cardiovascular Outcomes.

Authors:  Marlon E Cerf
Journal:  Medicina (Kaunas)       Date:  2018-10-11       Impact factor: 2.430

7.  Programming With Varying Dietary Fat Content Alters Cardiac Insulin Receptor, Glut4 and FoxO1 Immunoreactivity in Neonatal Rats, Whereas High Fat Programming Alters Cebpa Gene Expression in Neonatal Female Rats.

Authors:  Annelene Govindsamy; Samira Ghoor; Marlon E Cerf
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-05       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.